Clinical Trials
20 trialsNCT00102544 2026-06-05
Use of Tracking Devices to Locate Abnormalities During Invasive Procedures
National Institutes of Health Clinical Center (CC)
Phase NA Enrolling by invitation
NCT06788509 2026-06-05
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Janssen Research & Development, LLC
Phase 1 Enrolling by invitation
NCT07328516 2026-06-05
Natural History Study of Early Life Exposures in Agriculture (ELEA)
National Institutes of Health Clinical Center (CC)
Enrolling by invitation
NCT06940648 2026-06-02
VIABLE
Virtuoso Surgical, Inc.
Phase NA Enrolling by invitation
NCT06935097 2026-05-22
Mediterranean Diet Intervention Among Men at LBJ Hospital With Prostate Cancer
M.D. Anderson Cancer Center
Phase NA Enrolling by invitation
NCT07240857 2026-05-22
A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer
Zhejiang University
Phase EARLY_PHASE1 Enrolling by invitation
NCT06885424 2026-05-20
DESCENT-1
A2 Biotherapeutics Inc.
Enrolling by invitation
NCT04399876 2026-05-18
Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer
Brigham and Women's Hospital
Phase 1 Enrolling by invitation
NCT06204614 2026-05-18
Drug Screening Using IMD in Bladder Cancer
Brigham and Women's Hospital
Phase EARLY_PHASE1 Enrolling by invitation
NCT07557901 2026-05-15
A Study Comparing Infectious Complications After Transperineal Prostate Biopsy With or Without Antibiotic Prophylaxis
F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica
Phase NA Enrolling by invitation
NCT07583160 2026-05-13
YS247
Changhai Hospital
Phase 1 Enrolling by invitation
NCT04145375 2026-05-08
Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol
Zenith Epigenetics
Phase 1/2 Enrolling by invitation
NCT07218003 2026-05-04
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
Rondo Therapeutics
Phase 1 Enrolling by invitation
NCT07132073 2026-04-29
MRI-guided Locoregional SBRT Prostate Program
Clinica Universidad de Navarra, Universidad de Navarra
Phase NA Enrolling by invitation
NCT07439913 2026-04-27
Predictive Factors for 10-year Biochemical Recurrence and Urinary Continence Following Robot-assisted Radical Prostatectomy for Prostate Cancer
F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica
Enrolling by invitation
NCT05753046 2026-04-23
TAPBlock
Corewell Health East
Phase 4 Enrolling by invitation
NCT02759744 2026-04-21
Fusion Guided Focal Laser Ablation of Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase NA Enrolling by invitation
NCT07205783 2026-04-07
Open Radical Prostatectomy Versus Curative Radiotherapy for Treatment of Organ Confined Prostate Cancer (Retrospective Comparative Study)
Sohag University
Phase NA Enrolling by invitation
NCT07488572 2026-03-23
Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study
Sun Yat-sen University
Phase 2 Enrolling by invitation
NCT07474051 2026-03-16
PERSIST
AvenCell Therapeutics, Inc.
Enrolling by invitation